Home › Compare › GRDLY vs ABBV
GRDLY yields 3.69% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, GRDLY + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GRDLY + ABBV for your $10,000?
Grindrod Limited, together with its subsidiaries, engages in the logistics and financial services business in North America, Bermuda, South America, the Middle East, the United Kingdom, Isle of Man, rest of Europe, Singapore, Asia, the Far East, Australia, South Africa, and Rest of Africa. The company operates through Ports and Terminals, Logistics, Bank, Private Equity and Property, and Marine Fuels and Agricultural Logistics segments. It engages in the bulk terminal activities include receiving, stockpiling, and loading of cargo onto vessels for onward transportation; container handling, transport, warehousing, loading, and offloading; selling and leasing containers; and logistics solutions for the transportation of cargo through road, rail, and sea. The company also provides clearing and forwarding of imports and exports, transportation of goods, and ship husbandry services; and various ancillary services, including training, bay stevedoring, and rentals. In addition, it involves managing and handling port activities; freight services, such as handling and storage of containers, clearing and forwarding to road, rail, and seaborne freight; ships agency; and marine fuels, lubricants, bunkers, and agricultural commodities. Further, the company invests in private and property equity portfolios; and engages in the private equity investment business. Additionally, it offers financial services comprising cash deposit management services; overdrafts, term loans and invoice discounting facilities, and mezzanine finance; retail banking products and services; and property lending services. Grindrod Limited was founded in 1910 and is based in Durban, South Africa.
Full GRDLY Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.